BrightSpring Health (BTSG) Stock Price Target 2026

The average analyst price target for BrightSpring Health is $58.52, 15.6% below the current price. Of 19 analysts, 18 rate it Buy and 1 Hold. Targets range from $11.50 to $92. The latest change came on Nov 3, 2026, when Guggenheim raised its price target on BrightSpring Health from $81 to $84 and kept a Buy rating.

The Average Analyst Price Target for BrightSpring Health is $58.52.

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

1S.Buy

17Buy

1Hold

Consensus RatingBuy# Analysts19Avg. Consensus PT$58.52Upside to Avg. PT-15.6%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for BrightSpring Health Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 3, 2026	Guggenheim	Jason Cassorla	PT Raise	Buy	$81→$84
Nov 2, 2026	UBS	A.J. Rice	PT Raise	Buy	$85→$92
Nov 2, 2026	Leerink Partners	Whit Mayo	PT Raise	Outperform	$72→$92
Nov 2, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$81→$84
Nov 2, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$78→$82
Aug 13, 2026	BTIG	David Larsen	Maintained	Buy	$90
Aug 3, 2026	BTIG	David Larsen	Maintained	Buy	$90
Jul 14, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$71→$80
Jul 14, 2026	Keybanc	Matthew Gillmor	PT Raise	Overweight	$60→$80
Jul 13, 2026	Wells Fargo	Stephen Baxter	PT Raise	Overweight	$61→$78
Jul 13, 2026	Guggenheim	Jason Cassorla	Initiate	Buy	$81
Jul 10, 2026	Raymond James	Parker Snure	Initiate	Outperform	$80
Jul 8, 2026	UBS	A.J. Rice	PT Raise	Buy	$63→$85
Jul 2, 2026	B of A Securities	Kevin Fischbeck	PT Raise	Buy	$66→$77
Jun 22, 2026	BTIG	David Larsen	PT Raise	Buy	$65→$90
Jun 18, 2026	TD Cowen	Charles Rhyee	PT Raise	Buy	$65→$81
Jun 8, 2026	Goldman Sachs	Scott Fidel	Initiate	Buy	$71
Jun 2, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$62→$71
May 6, 2026	Morgan Stanley	Erin Wright	PT Raise	Overweight	$48→$62
May 5, 2026	Mizuho	Ann Hynes	PT Raise	Outperform	$52→$61